These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16296572)

  • 81. Nebivolol in obese and non-obese hypertensive patients.
    Manrique C; Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):309-15. PubMed ID: 19527321
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.
    Deedwania P; Shea J; Chen W; Brener L
    J Clin Hypertens (Greenwich); 2013 Apr; 15(4):270-8. PubMed ID: 23551727
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aortic elastic properties : effects of carvedilol versus nebivolol.
    Sayin MR; Aydin M; Dogan SM; Karabag T; Cetiner MA; Aktop Z
    Herz; 2013 May; 38(3):299-305. PubMed ID: 23263241
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of metoprolol and nebivolol on exercise blood pressure in patients with mild hypertension.
    Yazici HU; Ozduman H; Aydar Y; Birdane A
    ScientificWorldJournal; 2013; 2013():608683. PubMed ID: 24285938
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE; Gamboa A; Shibao CA; Arnold AC; Choi L; Black BK; Raj SR; Robertson D; Biaggioni I
    Hypertension; 2014 Dec; 64(6):1241-7. PubMed ID: 25267802
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect.
    Cleophas TJ; Grabowsky I; Niemeyer MG; Mäkel WM; van der Wall EE;
    Circulation; 2002 Apr; 105(14):1669-71. PubMed ID: 11940545
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.
    Schmidt AC; Graf C; Brixius K; Scholze J
    Clin Drug Investig; 2007; 27(12):841-9. PubMed ID: 18020542
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.
    Davis JT; Pasha DN; Khandrika S; Fung MM; Milic M; O'Connor DT
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):69-74. PubMed ID: 23282127
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study.
    Kook H; Hong SJ; Yang KS; Lee S; Kim JS; Park CG
    PLoS One; 2020; 15(9):e0239039. PubMed ID: 32915892
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly.
    Mazza A; Gil-Extremera B; Maldonato A; Toutouzas T; Pessina AC
    Blood Press; 2002; 11(3):182-8. PubMed ID: 12126265
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of nebivolol on left ventricular hypertrophy in hypertension.
    Liu GS; Wang LY; Nueten LV; Ooms LA; Borgers M; Janssen PA
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):549-51. PubMed ID: 10686666
    [No Abstract]   [Full Text] [Related]  

  • 92. Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina.
    Kusljugić Z; Divković K; Baraković F; Smajić E; Arslanagić A; Hadziomerović M; Fazlibegović E; Midzić Z; Abdović E; Krneta M; Celik R; Basić H; Avdić B; Delić A; Macić-Dzanković A; Keco N; Boskailo H
    Bosn J Basic Med Sci; 2005 Feb; 5(1):42-51. PubMed ID: 15771602
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Managing erectile dysfunction in hypertensive patients.
    Handler J
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):450-4. PubMed ID: 21649845
    [No Abstract]   [Full Text] [Related]  

  • 94. [Postmarketing study of efficacy and safety of losartan during the treatment of patients with mild and moderate hypertension: LOTAR (corrected) study].
    Vasilijević Z; Dimković N; Lazarević K; Burmazović S; Krstić N; Milanović S; Zorić S; Micić D
    Srp Arh Celok Lek; 2013; 141(1-2):22-8. PubMed ID: 23539906
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparative effects of a new cardioselective beta-blocker nebivolol and nifedipine sustained-release on 24-hour ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Lefebvre J; Provencher P; Arnott W
    J Clin Pharmacol; 1992 Jul; 32(7):660-6. PubMed ID: 1353507
    [TBL] [Abstract][Full Text] [Related]  

  • 96. New drugs for hypertension: what do they offer?
    Gradman AH; Vivas Y
    Curr Hypertens Rep; 2006 Oct; 8(5):425-32. PubMed ID: 16965731
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antihypertensive monotherapy and cardiovascular responses to an acoustic startle stimulus.
    Girard A; Holand S; Laude D; Elghozi JL
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):101-7. PubMed ID: 11152367
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Nebivolol (nebilet) a beta blocker of the third generation--also for patients with obstructive lung diseases?].
    Matthys H; Giebelhaus V; von Fallois J
    Z Kardiol; 2001 Oct; 90(10):760-5. PubMed ID: 11757472
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.
    Acelajado MC; Pisoni R; Dudenbostel T; Oparil S; Calhoun DA; Glasser SP
    J Am Soc Hypertens; 2012; 6(1):66-72. PubMed ID: 22024668
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.
    Uhlir O; Dvorak I; Gregor P; Malek I; Spinarova L; Vojacek J; Van Nueten L
    J Card Fail; 1997 Dec; 3(4):271-6. PubMed ID: 9547441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.